P119 Recurrence Score® result by the 21-gene assay before and after systemic neoadjuvant chemotherapy in patients with HR+ HER2-breast cancer. by N. Ciriaco, B. Vieites, M. Bellet, C. Castilla, P. Gómez Pardo, A. Pérez-Luque, M.Á. López, F.J. Salvador Bofill, L. Alfaro, J.M. Pérez García, M. Espinosa-Bravo, C. Flannery, C. Hagen, V. Peg

Get full text